Scott H. Watterson

1.4k total citations
32 papers, 707 citations indexed

About

Scott H. Watterson is a scholar working on Molecular Biology, Organic Chemistry and Epidemiology. According to data from OpenAlex, Scott H. Watterson has authored 32 papers receiving a total of 707 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Organic Chemistry and 8 papers in Epidemiology. Recurrent topics in Scott H. Watterson's work include Biochemical and Molecular Research (12 papers), Organic Chemistry Cycloaddition Reactions (8 papers) and Adenosine and Purinergic Signaling (7 papers). Scott H. Watterson is often cited by papers focused on Biochemical and Molecular Research (12 papers), Organic Chemistry Cycloaddition Reactions (8 papers) and Adenosine and Purinergic Signaling (7 papers). Scott H. Watterson collaborates with scholars based in United States, Sweden and Germany. Scott H. Watterson's co-authors include Albert Padwa, S. Shaun Murphree, Zhi‐Jie Ni, Edwin J. Iwanowicz, Catherine Fleener, James B. Thomas, Allan S. Wagman, Katherine A. Rouleau, Philippe G. Nantermet and Michael T. Crimmins and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and The Journal of Organic Chemistry.

In The Last Decade

Scott H. Watterson

31 papers receiving 685 citations

Peers

Scott H. Watterson
J. Adam Willardsen United States
Jorge Gomez‐Galeno United States
Stephen E. de Laszlo United States
Stefan Gradl United States
Stuart C. Wilson United Kingdom
Scot Campbell United States
Terrence L. Smalley United States
Robert E. Kyne United States
J. Adam Willardsen United States
Scott H. Watterson
Citations per year, relative to Scott H. Watterson Scott H. Watterson (= 1×) peers J. Adam Willardsen

Countries citing papers authored by Scott H. Watterson

Since Specialization
Citations

This map shows the geographic impact of Scott H. Watterson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott H. Watterson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott H. Watterson more than expected).

Fields of papers citing papers by Scott H. Watterson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott H. Watterson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott H. Watterson. The network helps show where Scott H. Watterson may publish in the future.

Co-authorship network of co-authors of Scott H. Watterson

This figure shows the co-authorship network connecting the top 25 collaborators of Scott H. Watterson. A scholar is included among the top collaborators of Scott H. Watterson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott H. Watterson. Scott H. Watterson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vasta, James D., Gregory Locke, Mark A. Pattoli, et al.. (2019). A High-Throughput BRET Cellular Target Engagement Assay Links Biochemical to Cellular Activity for Bruton’s Tyrosine Kinase. SLAS DISCOVERY. 25(2). 176–185. 9 indexed citations
2.
Yip, Shiuhang, Dauh‐Rurng Wu, Peng Li, et al.. (2018). Separation of Bruton’s tyrosine kinase inhibitor atropisomers by supercritical fluid chromatography. Journal of Chromatography A. 1586. 106–115. 11 indexed citations
3.
Gillooly, Kathleen M., Claudine Pulicicchio, Mark A. Pattoli, et al.. (2017). Bruton's tyrosine kinase inhibitor BMS-986142 in experimental models of rheumatoid arthritis enhances efficacy of agents representing clinical standard-of-care. PLoS ONE. 12(7). e0181782–e0181782. 47 indexed citations
4.
Zhu, Juliang, Bang‐Chi Chen, Scott H. Watterson, et al.. (2016). An Efficient Scale-Up Synthesis of BMS-520, a Potent and Selective Isoxazole-Containing S1P1 Receptor Agonist. Organic Process Research & Development. 20(5). 989–995. 11 indexed citations
5.
Dyckman, Alaric J., Charles M. Langevine, Claude Quesnelle, et al.. (2010). Imidazo[4,5-d]thiazolo[5,4-b]pyridine based inhibitors of IKK2: Synthesis, SAR, PK/PD and activity in a preclinical model of rheumatoid arthritis. Bioorganic & Medicinal Chemistry Letters. 21(1). 383–386. 7 indexed citations
6.
Kempson, James, Junqing Guo, Jagabandhu Das, et al.. (2009). Synthesis, initial SAR and biological evaluation of 1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-4-amine derived inhibitors of IκB kinase. Bioorganic & Medicinal Chemistry Letters. 19(10). 2646–2649. 16 indexed citations
7.
Watterson, Scott H., T. G. Murali Dhar, Zhongqi Shen, et al.. (2003). Novel inhibitors of IMPDH. Bioorganic & Medicinal Chemistry Letters. 13(3). 543–546. 23 indexed citations
8.
Chen, Ping, Derek Norris, T. G. Murali Dhar, et al.. (2003). Identification of novel and potent isoquinoline aminooxazole-Based IMPDH inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(7). 1345–1348. 21 indexed citations
9.
Dhar, T. G. Murali, Zhongqi Shen, Henry H. Gu, et al.. (2003). 3-Cyanoindole-based inhibitors of inosine monophosphate dehydrogenase: synthesis and initial structure–Activity relationships. Bioorganic & Medicinal Chemistry Letters. 13(20). 3557–3560. 31 indexed citations
10.
Watterson, Scott H., T. G. Murali Dhar, Shelley K. Ballentine, et al.. (2003). Novel indole-based inhibitors of IMPDH: introduction of hydrogen bond acceptors at indole C-3. Bioorganic & Medicinal Chemistry Letters. 13(7). 1273–1276. 30 indexed citations
11.
Iwanowicz, Edwin J., Scott H. Watterson, Junqing Guo, et al.. (2003). Inhibitors of inosine monophosphate dehydrogenase: SARs about the N-[3-Methoxy-4-(5-oxazolyl)phenyl moiety. Bioorganic & Medicinal Chemistry Letters. 13(12). 2059–2063. 18 indexed citations
12.
Dhar, T. G. Murali, Scott H. Watterson, Ping Chen, et al.. (2003). Quinolone-Based IMPDH inhibitors: introduction of basic residues on ring D and SAR of the corresponding mono, di and benzofused analogues. Bioorganic & Medicinal Chemistry Letters. 13(3). 547–551. 7 indexed citations
14.
Pitts, William J., Junqing Guo, T. G. Murali Dhar, et al.. (2002). Rapid synthesis of triazine inhibitors of inosine monophosphate dehydrogenase. Bioorganic & Medicinal Chemistry Letters. 12(16). 2137–2140. 31 indexed citations
15.
Watterson, Scott H., Chunjian Liu, T. G. Murali Dhar, et al.. (2002). Novel amide-based inhibitors of inosine 5′-monophosphate dehydrogenase. Bioorganic & Medicinal Chemistry Letters. 12(20). 2879–2882. 11 indexed citations
16.
Iwanowicz, Edwin J., Scott H. Watterson, Chunjian Liu, et al.. (2002). Novel guanidine-Based inhibitors of inosine monophosphate dehydrogenase. Bioorganic & Medicinal Chemistry Letters. 12(20). 2931–2934. 18 indexed citations
17.
Gu, Henry H., Edwin J. Iwanowicz, Junqing Guo, et al.. (2002). Novel diamide-Based inhibitors of IMPDH. Bioorganic & Medicinal Chemistry Letters. 12(9). 1323–1326. 17 indexed citations
18.
Padwa, Albert, et al.. (1998). Alkylation reactions of 3-(phenylsulfonyl)methyl substituted cyclopentenones. Tetrahedron. 54(33). 9651–9666. 6 indexed citations
19.
Padwa, Albert, et al.. (1995). Periselectivity in the base-catalyzed intramolecular [2+2]-cycloaddition reaction of 3-phenylsulfonyl-substituted propynes. Tetrahedron Letters. 36(26). 4521–4524. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026